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Summary 
RNA-centric biochemical purification is a general approach for studying the functions 
and mechanisms of noncoding RNAs. Here, we describe the experimental procedures for 
RNA Antisense Purification (RAP), a method for selective purification of endogenous 
RNA complexes from cell extracts that enables mapping of RNA interactions with 
chromatin. In RAP, the user crosslinks cells to fix endogenous RNA complexes and 
purifies these complexes through hybrid capture with biotinylated antisense oligos. DNA 
loci that interact with the target RNA are identified using high-throughput DNA 
sequencing.  
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1  Introduction 
 
Large noncoding RNAs (lncRNAs) – a class of RNAs >200 nucleotides long that do not 
encode proteins – are emerging as critical regulators of gene expression in mammals [1-
5]. Inspired in part by classical examples such as the X-inactive specific transcript (Xist), 
a popular hypothesis is that many lncRNAs regulate gene expression by interacting with 
chromatin-regulatory proteins and recruiting them to specific DNA target sites. Indeed, 
recent work indicates that lncRNAs can interact with diverse chromatin regulators [6-9], 
localize to specific sites in the genome [10-12], and may even establish nuclear 
subdomains that contain the co-regulated DNA loci [12, 13]. Together, these observations 
highlight the need to map RNA-chromatin interactions to identify direct targets of 
lncRNA complexes.  
 
Advances in RNA-centric biochemical purification have presented new opportunities for 
systematically mapping RNA interactions with chromatin [10-12]. RNA Antisense 
Purification (RAP) [12], as well as other recently developed methods like ChIRP [10] and 
CHART [11], captures a target RNA of interest through hybridization with antisense 
biotinylated oligos. By crosslinking endogenous macromolecular complexes prior to 
RNA capture, RAP allows for identification of proteins, RNA, and DNA loci that 
crosslink to and co-purify with the target RNA. Compared with previous approaches for 
examining RNA-chromatin interactions such as fluorescence in situ hybridization (FISH), 
RNA-centric biochemical purification enables genome-wide mapping of RNA-DNA 
interactions by coupling the protocol with high-throughput DNA sequencing (RAP-
DNA). Thus, RAP provides an important tool for systematic interrogation of lncRNA 
function and mechanism. 
 
Here, we describe the RAP technique for mapping RNA-chromatin interactions. 
Compared to similar protocols, the most distinctive and important feature of RAP is its 
use of long (120-nucleotide) capture probes tiled across the entire target RNA. This probe 
design strategy robustly captures any lncRNA and enables the use of stringent 
hybridization and wash conditions that dramatically reduce nonspecific interactions of 
off-target nucleic acids or proteins [12]. We have applied this protocol to investigate 
ncRNAs in mouse embryonic stem cells and fibroblasts; the method is readily adapted to 
other systems where large quantities of cells can be obtained.  
 
2  Materials 
Prepare all buffers and solutions with nuclease-free water.  Follow appropriate 
regulations when handling chemicals (e.g., guanidine thiocyanate) and disposing waste.  
 
2.1 Equipment 
1. Sonication instrument (e.g., Branson Sonifier with microtip) and chiller 
2. Magnetic rack for 1.5 mL tubes (e.g., Invitrogen DynaMag-2) 
3. PCR machine and real-time quantitative PCR machine 
4. Microcentrifuge 
5. NanoDrop Spectrophotometer  
6. Glass dounce 
7. Heated mixer with 1.5 mL rack (e.g., Eppendorf Thermomixer) 
 
2.2 Solutions 
Make stock solutions and store up to 6 months at room temperature, unless otherwise 
noted. 
1. Scraping Buffer: PBS, 0.5% BSA Fraction V. Store at 4°C. 
2. Cell Lysis Buffer: 10 mM HEPES pH 7.5, 20 mM KCl, 1.5 mM MgCl2, 0.5 mM 
EDTA. Before use, add fresh 1 mM tris(2-carboxyethyl)phosphine (TCEP) and 
0.5 mM phenylmethylsulfonyl fluoride (PMSF).  Store at 4°C. 
3. Nuclear Lysis Buffer:  20 mM HEPES pH 7.5, 50 mM KCl, 1.5 mM MnCl2, 1% 
IGEPAL CA630 (NP-40), 0.4% sodium deoxycholate, 0.1% N-lauroylsarcosine. 
Before use, add fresh 1 mM TCEP and 0.5 mM PMSF.  Store at 4°C. 
4. 100× DNase Cofactor Solution: 250 mM MnCl2, 50 mM CaCl2. 
5. 25× DNase Stop Solution: 250 mM EDTA, 125 mM EGTA. 
6. Hybridization Buffer (1×): 20 mM Tris-HCl pH 7.5, 7 mM EDTA, 3 mM EGTA, 
150 mM LiCl, 1% NP-40, 0.2% N-lauroylsarcosine, 0.1% sodium deoxycholate, 3 
M guanidine thiocyanate, 2.5 mM TCEP.  Prepare both 1× and 1.4× stock 
solutions. 
7. Wash Buffer: 20 mM Tris-HCl pH 7.5, 10 mM EDTA, 1% NP-40, 0.2% N-
lauroylsarcosine, 0.1% sodium deoxycholate, 3 M guanidine thiocyanate, 2.5 mM 
TCEP. 
8. RNase H Elution Buffer: 50 mM Tris-HCl pH 7.5, 75 mM NaCl, 3 mM MgCl2. 
Before use, add fresh 0.125% N-lauroylsarcosine, 0.025% sodium deoxycholate, 
2.5 mM TCEP. 
9. NLS Digestion Buffer: 20 mM Tris-HCl pH 7.5, 10 mM EDTA, 2% N-
lauroylsarcosine, 2.5 mM TCEP. 
 
2.3 Additional Materials and Reagents 
1. NEBNext High-Fidelity PCR Master Mix (NEB) 
2. T7 RNA Polymerase and 10× Buffer (NEB) 
3. Murine RNase Inhibitor (NEB) 
4. 100 mM ATP, CTP, GTP, UTP 
5. DNA purification kit: DNA Clean and Concentrator-5 (Zymo) 
6. RNA purification kits: RNA Clean and Concentrator-5 (Zymo), RNeasy Mini 
(Qiagen) 
7. TURBO DNase (Invitrogen) 
8. Multiple-temperature reverse-transcription reagents (e.g., AffinityScript Reverse 
Transcriptase and Buffer from Agilent) 
9. Cell scraper 
10. Disuccinimidyl glutarate (Pierce) 
11. 16% Formaldehyde solution in 10-mL ampules (Pierce) 
12. 2.5 M Glycine solution 
13. BSA Fraction V 
14. MyONE Streptavidin C1 magnetic beads (Invitrogen) 
15. MyONE SILANE magnetic beads (Invitrogen) 
16. 100 mM dithiothreitol (DTT) 
17. 10× RT Random Primers (Applied Biosystems) 
18. RT-qPCR reagents and PCR primers 
19. NEBNext Ultra DNA Library Prep Kit and Multiplex Primers (NEB) 
 
3  Methods 
3.1 Assay Design 
1. Choose a target RNA of interest.   
2. Choose appropriate negative control target sequences. For example, scramble the 
sequence of the target RNA to create a GC-content-matched control that does not 
exist in the cell. Alternatively, purify mRNAs, which likely do not interact with 
chromatin outside of their own genomic loci. 
3. Choose appropriate positive control targets to aid in optimizing lysis and 
purification conditions (see Note 1). 
 
3.2 Probe Design 
1. Design 90- to 120-nucleotide capture probes antisense to the target RNA 
sequences. Shorter probes (50-90 nucleotides) can also be used, provided GC 
content is >50%. Probes can be tiled across the entire transcript (e.g., each 120-
nucleotide probe overlaps the next probe by 105 nucleotides), or they can be 
divided into two non-overlapping probe pools (even and odd) for additional 
specificity (see Note 2). 
2. Omit probes that may hybridize to off-target sequences. Remove probes that 
contain more than 8 bases of any repetitive or low-complexity sequences as 
defined by RepeatMasker and Tandem Repeat Finder (these annotations can be 
viewed on the UCSC Genome Browser at http://genome.ucsc.edu). Remove 
probes that contain homo-polymers of more than 8 bases. Remove probes that 
align to other regions in the genome with 25 or more matching bases (e.g., with 
BLAT). 
3. Choose and validate RT-qPCR primers spanning a short amplicon (<90 bases) on 
the target RNA, and omit probes that overlap this region. This will enable qPCR 
measurement of purification yields and enrichments without confounding signal 
from residual amounts of the probes themselves. 
 3.3 Probe Generation  
The protocol below uses oligonucleotide library synthesis technology to simultaneously 
generate pools of ssDNA probes targeting many different RNAs.  Each probe set is 
tagged with unique PCR primers that allow for enrichment of specific probe sets from the 
total pool.  Probe sets are in vitro transcribed and then reverse transcribed with 
biotinylated primers to generate single-biotin ssDNA probes (see Note 3).  For alternative 
probe synthesis and amplification strategies, see Note 4.   
1. For each probe set, design unique PCR tags (20 base-pairs) with 65 °C annealing 
temperatures (hereafter, Left Tag Primer and Right Tag Primer).  Append the 
PCR tags to the ends of each probe in a given probe set such that the Left Tag 
Primer is on the 5’ end of the oligo sequence and the Right Tag Primer is on the 
3’ end of the oligo sequence (which is itself antisense to the target RNA). 
2. Order the pool of ssDNA oligos from an oligo library synthesis company (e.g., 
CustomArray, Inc.).  
3. Resuspend the lyophilized oligo pool in water to a final concentration of 10 nM. 
Aliquot and store at -20 °C.  
4. Order primers: for each probe set, order (i) Left Tag and Right Tag primers; (ii) 
T7-Left Tag and T7-Right Tag Primers, which are comprised of Left Tag and 
Right Tag Primers each following a T7 promoter sequence (e.g., 
GGATTCTAATACGACTCACTATAGGG-Left Tag Primer); and (iii) 5’-
biotinylated Left Tag and Right Tag Primers. 
5. For each probe set, enrich the component probes from the oligo pool using the 
unique PCR tags.  Set up PCR reaction on ice: 
• 1 µL of Oligo Pool (10 nM) 
• 1 µL of Tag Primer Left (25 µM) 
• 1 µL of Tag Primer Right (25 µM) 
• 25 µL of NEBNext High Fidelity 2× Master Mix (NEB) 
• 22 µL H2O 
6. Run PCR program:   
• 98 °C for 30 sec 
• 25-35 cycles of 98 °C for 10 sec, 65 °C for 20 sec, 72°C for 20 sec 
• 72 °C for 60 sec 
• 4 °C hold 
7. Clean the PCR product using a DNA purification column according to 
manufacturer’s protocol. Measure DNA yield using a NanoDrop 
spectrophotometer. Examine the dsDNA product on an agarose gel. If necessary, 
repeat PCR varying the annealing temperature, oligo pool amount, or number of 
cycles until the reaction produces a single clean band at the appropriate size (see 
Note 5). 
8. For each probe set, perform a second round of PCR amplification to add the T7 
promoter sequence (GGATTCTAATACGACTCACTATAGGG). Set up two 
PCR reactions to add the T7 promoter sequence onto one or the other end of the 
dsDNA template, allowing for generation of both sense and antisense probes. To 
generate antisense ssDNA probes that capture the target RNA, for example, use 
Tag Primer Left with T7-Tag Primer Right. 
• 1 µL of diluted enriched dsDNA (~1 nM) 
• 2 µL of primer mix (mix contains 25 µM of each primer) 
• 25 µL of NEBNext High Fidelity 2× Master Mix 
• 22 µL H2O 
9. Run PCR program: 
• 98 °C for 30 sec 
• 12-15 cycles of 98 °C for 10 sec, 65 °C for 20 sec, 72°C for 20 sec 
• 72 °C for 60 sec 
• 4 °C hold 
10. Clean the PCR product using a DNA purification column according to 
manufacturer’s protocol. Measure DNA yield using a NanoDrop 
spectrophotometer. Examine the dsDNA product on an agarose gel. If necessary, 
repeat PCR varying the annealing temperature or number of cycles until the 
reaction produces a single clean band at the appropriate size. If necessary, 
perform multiple PCR reactions to generate >250 ng of dsDNA T7 template for in 
vitro transcription. 
11. For each probe set, set up a 40 µL in vitro transcription reaction: 
• 24.2 µL T7 DNA template (250 ng total) 
• 4 µL 10× RNA Polymerase Reaction Buffer 
• 2 µL each 100 mM ATP, CTP, GTP, UTP 
• 3 µL T7 RNA Polymerase 
• 0.4 µL 100 mM DTT 
• 0.4 µL Murine RNase Inhibitor 
12. Mix well by pipetting. Incubate at 37 °C overnight. 
13. Next day, transfer reaction to 85 °C for 3 minutes.  Afterward, place immediately 
on ice for 1 min. 
14. To digest dsDNA templates, add 42 µL H2O, 10 µL TURBO DNase Buffer, and 8 
µL TURBO DNase (100 µL total volume). Incubate at 37 °C for 15 minutes. 
15. Purify RNA, using sufficient ethanol to precipitate the ~150-nucleotide RNA 
fragments. For example, use an RNeasy Mini column (maximum capacity 100 µg 
RNA): Add 3.5× RLT (350 µL) to sample and mix well. Add 1.5× 100% ethanol 
(775 µL) to sample-RLT mixture and mix well. Transfer 700 µL to the RNeasy 
Mini column, and spin for 15 seconds at >8,000× g. Discard flow-through and 
repeat with remaining sample. Add 500 µL Buffer RPE to column and spin for 15 
seconds. Discard flow-through. Repeat wash step. Transfer column to fresh 
collection tube and spin for 2 minutes to remove residual Buffer RPE. Transfer 
column to 1.5 mL tube; add 30 µL H2O and spin for 1 minute to elute. 
16. Measure RNA yield with a NanoDrop and dilute to a convenient concentration 
(e.g., 1 µg/µL).  Ideally yield should be >50 µg for a 40 µL reaction. 
17. Run RNA on gel to confirm the correct size of the in vitro transcription product. 
18. To generate ssDNA, set up a 200 µL reverse transcription reaction: 
• 120 µL RNA template (10 µg) + H2O 
• 20 µL 100 µM 5’-biotinylated Left Tag Primer 
• 20 µL 10× AffinityScript Buffer 
• 20 µL 100 mM DTT 
• 8 µL 100 mM dNTP (25 mM each) 
• 10 µL AffinityScript Reverse Transcriptase Enzyme 
• 2.5 µL RNase Inhibitor 
19. Incubate at 55 °C for 50 minutes, then 75 °C for 5 minutes. 
20. To degrade RNA templates, add 0.1× (20 µL) 1 M NaOH. Incubate at 75 °C for 
another 10 minutes. 
21. Add 0.1× (20 µL) 1 M acetic acid to neutralize. 
22. Clean up the ssDNA product and eliminate the unused primer by size selection. 
For example, use a Zymo RNA Concentrator-5 column: Add 2× volume RNA 
Binding Buffer (480 µL) and mix well; add 1.9× original volume 100% ethanol 
(456 µL) and mix well. Transfer 700 µL to column; spin at 12,000× g for 1 
minute. Discard flow-through and repeat with remaining sample. Add 400 µL 
RNA Prep Buffer; spin for 30 seconds and discard flow-through. Add 700 µL 
RNA Wash Buffer; spin and discard flow-through. Repeat the wash step with 400 
µL RNA Wash Buffer. Transfer column to clean collection tube and spin for 2 
minutes. Transfer column to a 1.5 mL tube, add 30 µL of water, and spin at 
10,000× g for 1 minute to elute.  
23. Measure the yield with a NanoDrop. Ideal yield should be ~3 µg ssDNA for a 200 
µL reverse transcription reaction.  
24. Freeze biotinylated ssDNA probe until use. 
 
3.4 Cell Harvesting and Crosslinking 
This protocol describes the steps for adherent cells. To adapt for suspension cells, spin 
cells between steps and decant supernatant to exchange buffers.  
1. Before starting, heat one aliquot PBS at 37 °C and chill one aliquot at 4 °C (see 
below for volumes). 
2. Grow adherent cells on 15-cm tissue culture plates. Before crosslinking, carefully 
split and count one plate (see Note 6). 
3. Resuspend 50 mg of disuccinimidyl glutarate (DSG) in 306 µL room-temperature 
DMSO to create a 0.5 M stock solution. 
4. Dilute DSG to 2 mM in room-temperature PBS. Prepare 7 mL of 2 mM DSG for 
each 15-cm plate. 
5. Remove media from cells. Rinse cells in plate with 10 mL room temperature PBS. 
Discard PBS. 
6. Add 7-10 mL of 2 mM DSG solution and rock plates gently at room temperature 
for 45 minutes to crosslink (see Note 7). 
7. Immediately before using, prepare a 3% formaldehyde solution in PBS preheated 
to 37 °C. Use a fresh ampule of 16% formaldehyde (Pierce).  
8. Remove DSG solution from cells and rinse once with room temperature PBS. 
9. Add 7 mL warmed 3% formaldehyde solution to cells. Incubate at 37 °C for 10 
minutes, gently rocking by hand every 3 minutes. 
10. Quench formaldehyde crosslinking by adding glycine to a final concentration of 
500 mM. Incubate at 37 °C for 5 minutes. 
11. Discard formaldehyde waste in appropriate disposal container. 
12. Rinse cells three times with cold PBS. Avoid dislodging cells from plate. 
13. After last wash, add 2 mL of ice-cold Scraping Buffer to each 15-cm plate. From 
this point, keep cells at 4 °C. 
14. Scrape cells from plate and transfer to a 15-mL Falcon tube. 
15. Centrifuge at 1,000× g at 4 °C for 5 minutes to pellet cells. 
16. Discard supernatant and resuspend pellet in 1 mL ice-cold Scraping Buffer to 
break up the pellet. Add more Scraping Buffer if necessary for convenient 
aliquoting (e.g., add 1 mL of Scraping Buffer for every 20 million cells). 
17. Aliquot cells into microcentrifuge tubes (20 million cells each) and spin at 2,000× 
g at 4 °C for 5 minutes. 
18. Remove supernatant and flash freeze pellets in liquid nitrogen. Store until cell 
lysis at -80 °C. 
 
3.5 Cell Lysis 
All steps and buffers should be cooled to 4 °C. 
1. Thaw cell pellets by completely resuspending 20 million cells in 1 mL Cell Lysis 
Buffer (add TCEP and PMSF fresh) in a 1.5 mL microcentrifuge tube. 
2. Pellet cells by spinning at 3,300× g for 7 minutes. Remove supernatant. 
3. Gently resuspend swelled cells in 1 mL ice cold Cell Lysis Buffer pre-mixed with 
0.1% NP-40. Incubate on ice for 10 minutes. 
4. Transfer to an ice-cold glass dounce of appropriate size (e.g., 2 mL). Homogenize 
cell lysate by douncing 20×. 
5. Transfer cells back to a microcentrifuge tube and pellet nuclei by spinning at 
3,300× g for 7 minutes. Remove supernatant. 
6. Resuspend nuclei in 1 mL of Nuclear Lysis Buffer (add TCEP and PMSF fresh). 
Incubate on ice for 10 minutes. 
7. Sonicate using a Branson Sonifier fitted with a microtip using 5 Watts of power 
for 2 minutes in pulses: 0.7 seconds on, 3.3 seconds off (see Note 8). 
8. Split sample into two separate microcentrifuge tubes, each with 500 µL lysate. 
9. To each, add 6 µL of 100× DNase Cofactor Solution and 50-100 µL TURBO 
DNase (see Notes 9 and 10). Mix by pipet. 
10. Transfer to a 37 °C heat block and incubate for 10-15 minutes (see Note 10).  
11. Return sample to ice and immediately halt DNase reaction by adding 24 µL of 
DNase Stop Solution. Mix immediately by pipetting. 
12. Remove and save a 5 µL aliquot of lysate (pre-clear). 
13. Mix ~600 µL of lysate with 1.5 mL of 1.4× concentrated Hybridization Buffer. 
14. Clear lysate by spinning at maximum speed (16,000× g) for 10 minutes. 
15. Remove and save a 5 µL aliquot of lysate (post-clear). 
16. Flash-freeze aliquots of lysate in liquid nitrogen and store at -80 °C. 
17. To check quantities and sizes of RNA and DNA in saved aliquots of lysate (Steps 
12 and 15 above), first add 40 µL of NLS Digestion Buffer, 2.5 µL of 5 M NaCl, 
and 2.5 µL Proteinase K (see Note 11), and incubate at 65°C for 60 minutes. 
18. Clean and purify nucleic acids as desired (e.g., ethanol precipitation).  
19. Split in half; treat half with DNase and half with RNase, and incubate for 37 °C 
for 10 minutes. 
20. Clean and purify nucleic acids.  Elute in 10 µL H2O. 
21. Quantify DNA yields with a NanoDrop spectrophotometer (see Note 12). 
22. Assess fragment sizes with the Agilent Bioanalyzer (High-Sensitivity DNA and 
RNA Pico kits). Ideal fragment sizes (pre-clear) are shown in Figure 1. 
 3.6 Lysate Preparation  
1. Thaw lysate corresponding to 5 million cells for each sample (see Note 13). 
2. Aliquot out 100 µL MyONE Streptavidin C1 magnetic beads for each purification 
from 5 million cells.  
3. Wash beads twice in 0.5× original bead volume Hybridization Buffer, using a 
magnetic rack to capture beads and remove wash buffers each time. When 
separating magnetic beads from solution, place sample on magnet and wait 1-2 
minutes before proceeding to allow beads to completely separate. 
4. Resuspend beads in 0.25× bead volume Hybridization Buffer. Add beads to lysate 
(i.e., 25 µL concentrated beads to 1 mL of lysate containing 5 million cells). 
5. Incubate at 37 °C for 20-30 minutes, shaking.  
6. Magnetically separate and transfer supernatant (streptavidin-cleared lysate) to a 
clean tube. Repeat this step to completely remove beads. 
7. Save 5 µL of pre-cleared lysate (0.5% total input) on ice as DNA input. 
8. Re-warm lysate to 37 °C, then proceed immediately to hybridization. 
 
3.7 Hybridization, Capture, Wash, Elute 
Prepare wash and elution buffers beforehand. Equilibrate solutions to the indicated 
temperatures before adding to samples. 
1. Aliquot out 50 pmol of biotinylated ssDNA probe for each purification from 5 
million cells. 
2. Denature probe in H2O at 85 °C for 3 minutes and then transfer immediately to 
ice. 
3. Add probe to lysate, mix, and immediately transfer to a 37 °C Thermomixer.  
4. Incubate at 37 °C for 2-3 hours, shaking at 1,200 r.p.m. 
5. Just before use, aliquot out 500 µL of Streptavidin C1 magnetic beads for each 
sample. Wash twice in 0.5× bead volume Hybridization Buffer, then resuspend in 
0.25× bead volume Hybridization Buffer. Add beads to sample and incubate at 37 
°C for 15-30 minutes, shaking. 
6. Magnetically separate and then remove supernatant. Optional: save supernatant 
for quality control steps (see Note 14).  
7. Resuspend beads in 1× original bead volume (500 µL) Wash Buffer, then 
incubate at 45 °C for 3-10 minutes while washing other samples. Wash a total of 
6 times. When removing final wash: place on magnet, remove liquid, spin down 
tube briefly, and remove the last drops of wash buffer with a fine tip. 
8. Wash with 1× bead volume RNase H Elution Buffer (add TCEP and detergents 
fresh). 
9. Wash with 100 µL RNase H Elution Buffer (add TCEP and detergents fresh). 
Transfer samples to new tube before removing the final wash. 
10. To elute, add 55 µL RNase Elution Buffer and 7.5 µL RNase H to each sample. 
11. Incubate at 37 °C for 30 minutes, shaking. 
12. Remove and save eluate. 
13. Add 62.5 µL Hybridization Buffer and incubate at 37 °C for 5 minutes, shaking. 
14. Remove eluate and combine with previous eluate. 
15. Magnetically separate the combined eluates once more and transfer to a new tube 
to remove any residual beads and attached ssDNA probe. 
16. Add 312.5 NLS Digestion Buffer, 50 µL 5 M NaCl, and 12.5 µL Proteinase K to 
each sample and to the saved input sample. Proceed to DNA or RNA analysis 
section. Alternatively, divide sample for both RNA and DNA analysis (see Note 
15); for example, use 50 µL for RNA analysis and 450 µL for DNA analysis. 
 
3.8 RNA Analysis 
1. Mix well, and incubate tubes for 1 hour at 65 °C to digest protein and reverse 
formaldehyde crosslinks.  
2. Clean and purify nucleic acids (e.g., using Zymo RNA Concentrator-5 columns). 
Elute in 15 µL H2O. 
3. Add 2 µL 10× TURBO DNase Buffer, 2 µL TURBO DNase to digest genomic 
DNA, and 1 µL Exonuclease I to digest residual ssDNA probe. Incubate at 37 °C 
for 15 minutes. 
4. Clean and purify nucleic acids (e.g., using Zymo RNA Concentrator-5 columns). 
Elute in 12.2 µL H2O. 
5. Set up reverse transcription reaction: 
• 12.2 µL RNA 
• 2 µL 10× RT Random Primers 
• 2 µL 10× AffinityScript Buffer 
• 2 µL 100 mM DTT 
• 0.8 µL 100 mM dNTPs (25 mM each) 
• 1 µL AffinityScript RT Enzyme 
6. Mix. Incubate at 25 °C for 10 minutes, 55 °C for 50 minutes, and 70 °C for 15 
minutes. 
7. Place samples on ice. Dilute cDNA by adding 180 µL H2O. 
8. Analyze cDNAs using quantitative real-time PCR to determine enrichment and 
yield of the target RNA (see Note 16). Primers should include one or more primer 
pairs for the target RNA as well as multiple primer pairs targeting other abundant 
RNAs (e.g., 18S rRNA, U1 snRNA).  
9. Calculate enrichment as the ratio of the amount of the target RNA in the target 
purification versus negative-control purification, normalized to the ratio of the 
signal of abundant RNAs in the target purification versus negative-control 
purification. Calculate yield as the ratio of the amount of the target RNA in the 
target purification versus the input, accounting for the fraction of input saved in 
Section 3.6 Step 7. 
 
3.9 DNA Analysis 
1. Mix well, and incubate tubes overnight at 60 °C to digest protein and completely 
reverse formaldehyde crosslinks.  
2. Clean and purify DNA. 
3. If desired, analyze genomic DNA using quantitative real-time PCR to determine 
enrichment and yield of target DNA (see Note 17). 
4. Generate DNA sequencing libraries for high-throughput DNA sequencing using 
the NEBNext Ultra DNA Library Prep Kit for Illumina using the manufacturer’s 
protocol. Sequence the DNA libraries to generate ~20 million reads for the RAP 
samples and 30-80 million reads for the input samples (see Note 18). 
 
4  Notes 
1. As a positive control, we suggest purifying the highly abundant U1 snRNA. In 







2. Nonspecific hybridization of probes to off-target RNAs or DNA loci is a major 
concern for hybridization-based purification strategies. RAP uses highly 
denaturing and stringent hybridization conditions to ensure capture specificity. 
However, nonspecific interactions are difficult to predict and will be different for 
each new target RNA, and so we recommend using two independent probe sets in 
an even/odd design to provide additional confidence in RNA-chromatin 
interactions identified with RAP. 
3. Single-stranded DNA probes provide better specificity than the RNA probes used 
in previous iterations of this protocol [12]. 
4. An alternative strategy for obtaining RAP probes is to order 5’ biotinylated oligos 
from a commercial supplier. Compared to the protocol presented above, ordering 
ready-to-use biotinylated probes from a commercial supplier potentially provides 
a faster and cheaper alternative for obtaining large amounts of a smaller number 
of probes.  
5. In some cases, specific amplification of subsets of the oligo pool can be 
challenging, depending on the quality of the oligo synthesis and the complexity of 
the oligo pool. We typically order oligo pools with 12,000 unique sequences from 
Custom Array, Inc. and achieve robust amplification of full-length product. 
6. Accurate cell counts are critical for maintaining consistency between cell and 
lysate batches because cell numbers affect the efficiency of the sonication and 
DNase treatment during lysis. We typically harvest and crosslink 100-200 million 
cells in parallel and freeze multiple 20-million cell pellets; one of these pellets is 
spent to optimize lysis conditions, and the rest are used for purification 
experiments. 
7. For some cell types, reducing the crosslinking amount (e.g., to 2% formaldehyde) 
or reducing the length of the DSG treatment may allow for better lysis and 
solubilization. 
8. Samples should be kept cold during sonication, for example by holding the 
sample in a 4 °C chilling rack or ice bath. Depending on the length of sonication 
and the efficiency of the cooling strategy, longer breaks between sonication pulses 
may help to keep samples cool. 
9. TURBO DNase works better than standard DNase I here because it works more 
robustly in high-salt solutions. 
10. Optimization of the lysis conditions (amount of sonication, amount/timing of 
DNase) is a critical step in establishing the protocol for the first time. The length 
of sonication might vary from 1-4 minutes, and DNase treatment might vary from 
10 to 20 minutes, depending on cell number, ploidy, and crosslinking strength. To 
optimize DNase timing and conditions, remove 5 µL lysate aliquots every 2-4 
minutes, quench with EDTA and EGTA on ice, and assay RNA and DNA sizes 
for each time point as described in the protocol. In optimizing the lysis conditions, 
the goals are (i) to solubilize as much chromatin as possible (assayed by 
comparing DNA concentrations from lysate before and after the clearing spin in 
Section 3.5 Step 14), (ii) to digest the DNA to appropriate fragment sizes for 
DNA sequencing (with a significant fraction of fragments in the range of 100-600 
basepairs as assayed by gel electrophoresis or Bioanalyzer), and (iii) to avoid 
severe degradation of cellular RNA (assayed by gel electrophoresis or 
Bioanalyzer). We recommend trying several different lysis conditions and 
comparing the results obtained when performing RAP on a positive control target 
RNA. If an appropriate combination of solubilization and RNA/DNA fragment 
sizes cannot be obtained by varying the amount of sonication or DNase, then 
reducing the strength of the crosslinking may be necessary. 
11. The Hybridization Buffer contains 3 M guanidine thiocyanate, which precipitates 
sodium dodecyl sulfate (SDS) detergent; do not use SDS in buffers in place of N-
lauroylsarcosine. High concentrations of guanidine thiocyanate at high 
temperature will denature dsDNA fragments: in order to avoid denaturing 
dsDNA, dilute final guanidine thiocyanate concentration 8-fold (to less than 375 
mM final concentration) during any Proteinase K digestion. 
12. Accounting for the dilution of the lysate between the pre-clear and post-clear 
aliquots, we typically find that the post-clear aliquots contains >50% of the DNA 
of the pre-clear aliquot, indicating successful solubilization of chromatin. 
13. We have found that 5 million cells per sample is more than enough to map RNA-
chromatin interactions for abundant noncoding RNAs like Xist or U1; for lower-
abundance RNAs, more cells may be necessary. In this case, scale up probe 
amounts and reaction volumes accordingly. 
14. When establishing and troubleshooting the assay, it may be useful to save the 
supernatant, treat with Proteinase K, and isolate RNA and/or DNA to examine (i) 
the integrity of the RNA at the end of the hybridization, (ii) the amount of target 
RNA/DNA remaining in the supernatant after capture, and (iii) the amount of 
probe remaining in the supernatant after capture. 
15. RNA analysis should be used initially to validate capture of the target RNA. After 
establishing the reproducibility of the assay, RNA analysis can be skipped and the 
entire sample can be used for DNA analysis. 
16. RNA enrichments are typically in the range of 100-1,000-fold versus negative 
controls. RNA yields are typically in the range of 10-80%, depending on the 
target RNA.  If low RNA (or DNA) enrichments are observed with high yield, 
one possible reason is that crosslinked macromolecular complexes are too large 
due to over-crosslinking or insufficient sonication; try decreasing crosslinking or 
increasing sonication.  If low RNA (or DNA) enrichments are observed with low 
yield, then there are multiple possibilities to consider. First, RNA may be 
degraded throughout the process, leading to poor capture; to address this, examine 
RNA integrity and yields at each intermediate step by RT-qPCR and/or 
visualization of RNA sizes with the Bioanalyzer. Second, the probe set may not 
properly capture the target RNA even with acceptable RNA integrity; to test this, 
use the same probe set to capture the target RNA in purified total RNA using the 
same protocol, and/or test the protocol in lysate using an abundant positive 
control RNA. 
17. In initial experiments, measure DNA yields and enrichments using quantitative 
PCR to validate that the experiment worked before moving immediately to DNA 
sequencing. Primers should include one or more primer pairs that measure 
genomic DNA close to but not overlapping the target gene locus; these regions 
should be strongly enriched (>100-fold) compared to input after normalizing to 
other locations in the genome. An appropriate negative control for this assay is 
comparing RAP with antisense probes to RAP with sense probes, which will 
capture DNA at the target locus but not RNA; the antisense probes should enrich 
more strongly for genomic DNA close to the target gene locus. Depending on the 
abundance of the target RNA, it may be necessary to use the entire DNA sample 
for qPCR, rather than saving some for DNA sequencing, to ensure that the DNA 
levels are high enough to meet the threshold for qPCR quantification. 
18. Proper analysis of the data, including identification of RNA-chromatin interaction 
sites and calculation of enrichments across different regions of the genome, 
requires deep sequencing of the input library because DNA fragment density can 
vary substantially across the genome [12]. 
 
5  References 
1. Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the 
mammalian genome. Science 2005;309(5740):1559–63.  
2. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand 
highly conserved large non-coding RNAs in mammals. Nature 
2009;458(7235):223–7.  
3. Guttman M, Garber M, Levin JZ, et al. Ab initio reconstruction of cell type-
specific transcriptomes in mouse reveals the conserved multi-exonic structure of 
lincRNAs. Nat Biotechnol 2010;28(5):503–10.  
4. Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large 
intergenic noncoding RNAs reveals global properties and specific subclasses. 
Genes Dev 2011;25(18):1915–27.  
5. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long 
noncoding RNAs: analysis of their gene structure, evolution, and expression. 
Genome Res 2012;22(9):1775–89.  
6. Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry 
controlling pluripotency and differentiation. Nature 2011;477(7364):295–300.  
7. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of 
histone modification complexes. Science 2010;329(5992):689–93.  
8. Nagano T, Mitchell JA, Sanz LA, et al. The Air noncoding RNA epigenetically 
silences transcription by targeting G9a to chromatin. Science 
2008;322(5908):1717–20.  
9. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short 
repeat RNA to the mouse X chromosome. Science 2008;322(5902):750–6.  
10. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic Maps of Long 
Noncoding RNA Occupancy Reveal Principles of RNA-Chromatin Interactions. 
Mol Cell 2011; 
11. Simon MD, Wang CI, Kharchenko PV, et al. The genomic binding sites of a 
noncoding RNA. Proc Natl Acad Sci U S A 2011;108(51):20497–502.  
12. Engreitz JM, Pandya-Jones A, McDonel P, et al. The Xist lncRNA exploits three-
dimensional genome architecture to spread across the X chromosome. Science 
2013;341(6147):1237973.  
13. Hacisuleyman E, Goff LA, Trapnell C, et al. Topological organization of 
multichromosomal regions by the long intergenic noncoding RNA Firre. Nat 




Figure 1.  DNA and RNA fragment sizes after lysis. 
(A) Example distribution of DNA fragment sizes (pre-clear). Sizes are measured with the 
High Sensitivity DNA Bioanalyzer assay. (B) Example distribution of RNA fragment 
sizes (pre-clear). Sizes are measured with the RNA 6000 Pico Bioanalyzer assay. FU = 
fluorescence units measured by Bioanalyzer. 
